Clinical Trials Sponsored by Shen Zhen Wingor Biotechnology CO. LTD

Total 27 results

Beijing 302 Hospital
Shenzhen Third People's Hospital; Shulan (Hang Zhou) Hospital; BeijingYouan Hospital and other collaborators

Recruiting

Human Umbilical Cord Mesenchymal Stem Cell Transplantation for The Treatment of Acute-on-Chronic Liver Failure

Acute-On-Chronic Liver Failure

China
BAIYONG SHEN
GeneCast Biotechnology Co., Ltd.

Not yet recruiting

ctDNA-based Minimal Residual Disease Detection for Resected Pancreatic Adenocarcinoma

Pancreatic Cancer Resectable

China
BAIYONG SHEN
GeneCast Biotechnology Co., Ltd.

Completed

Molecular Subtyping for Prognosis Evaluation in Resected Pancreatic Adenocarcinoma

Pancreatic Cancer Resectable

China
Chen Yi Enterprise, Co., Ltd.

Completed

Effectiveness of Nanoone Woman Underwear Using in the Management of Dysmenorrhea

Dysmenorrhea

Taiwan
Dalian Zhen-Ao Bio-Tech Co., Ltd.

Unknown

Phase IIaTrials of GanMaoKangNing Granules

Epidemic Influenza

China
Dalian Zhen-Ao Bio-Tech Co., Ltd.

Unknown

Clinical Study of Cardiomyopeptidin on Postoperative Ischemia-reperfusion Injury in Patients With Primary PCI

Left Ventricular Ejection Fraction | Survival Myocardial Area After Acute Myocardial Death
Shen Lin
RemeGen Co., Ltd.

Not yet recruiting

Real-world Study of HER2-overexpressed Advanced Solid Tumors After Progression of First-line Standard Therapy

Advanced Solid Tumor | Advanced Gastric Cancer | Advanced Gastroesophageal Junction Adenocarcinoma | HER2

China
Luye Pharma Group Ltd.
Shan Dong Boan Biotechnology Co., Ltd(Co-sponsor)

Not yet recruiting

A Study to Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration（wAMD）

Age Related Macular Degeneration
Luye Pharma Group Ltd.
Shan Dong Boan Biotechnology Co., Ltd

Active, not recruiting

A Study to Evaluate LY06006 and Prolia in Healthy Adults

Healthy Adults

China
Chinese PLA General Hospital
Dalian Zhen-Ao Bio-Tech Co., Ltd.

Active, not recruiting

A Randomized, Single-blind, Controlled Clinical Study of Cardiomyopeptidin on Improving Ischemia-reperfusion Injury in Patients With Acute ST-segment Elevation Myocardial Infarction After Primary PCI

Cardiovascular Diseases

China
GuangZhou WeiShiBo Biotechnology Co., ltd
Sun Yat-sen University

Completed

The Exploratory Clinical Trials for the Feasibility, Primary Safety and Efficacy of Foldable Capsular Vitreous Body

Retinal Detachment

China
Sun Yat-sen University
Akeso; Haplox Biotechnology Co., Ltd.

Recruiting

Combination of AK104 and Neoadjuvant Chemoradiotherapy in pMMR/MSS Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

China
Guangzhou FineImmune Biotechnology Co., LTD.
Sun Yat-sen University

Recruiting

Individualized Tumor Specific TCR- T Cells in the Treatment of Advanced Solid Tumors

Solid Tumor

China
GuangZhou WeiShiBo Biotechnology Co., ltd
Sun Yat-sen University

Unknown

Flexibility, Efficacy, and Safety of a Foldable Capsular Vitreous Body in the Treatment of Severe Retinal Detachment

Retinal Detachment

China
Sheng Hu
Wuhan Binhui Biotechnology Co., Ltd.

Recruiting

Safety and Efficacy Study of Virus Activated Killer Immune Cells (VAK) for Malignant Pleural and Peritoneal Effusion

Malignant Pleural Effusion | Malignant Peritoneal Effusion

China
WeiWei Xiao
Haplox Biotechnology Co., Ltd.

Recruiting

Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology

Minimal Residual Disease | Circulating Tumor DNA | Rectal Adenocarcinoma | Neoadjuvant Chemoradiotherapy

China
Yanhong Deng
GeneCast Biotechnology Co., Ltd.

Recruiting

Neoadjuvant Chemoradiotherapy Plus Sintilimab for Intermediate/High Immunoscore Locally Advanced Rectal Cancer (SILAR)

Rectal Cancer

China
Sun Yat-sen University
Tianjin Hengjia Biotechnology Development co., LTD

Recruiting

Phase I Study of Individualized Neoantigen Peptides in the Treatment of EGFR Mutant Non-small Cell Lung Cancer

Non Small Cell Lung Cancer

China
Sun Yat-sen University
GeneCast Biotechnology Co., Ltd.; Allist Pharmaceuticals, Inc.

Recruiting

Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA (FOCUS-C)

Non-small Cell Lung Cancer

China
Chen Xiangmei
Tianjin TongRenTang Group Co., Ltd.

Unknown

Safety and Efficacy of Shenyankangfu Tablets for Chronic Kidney Disease

Chronic Kidney Disease

China
Chen Xiangmei
Jiangsu Suzhong Pharmaceutical Group Co., Ltd.

Unknown

Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy

IgA Nephropathy

China
Wan-Guang Zhang
BeiGene; Geneplus-Beijing Co. Ltd.; Simcere Pharmaceutical Co., Ltd; Chinese Cooperative... and other collaborators

Recruiting

Nocardia Rubra Cell Wall Skeleton (N-CWS) Plus HAIC, Lenvatinib and Tislelizumab in Treating Patients With Advanced HCC (CCGLC-007)

Hepatocellular Carcinoma

China
Tongji Hospital
Gelesis, Inc.; Geneplus-Beijing Co. Ltd.; Chinese Cooperative Group of Liver... and other collaborators

Recruiting

Primary Hepatobiliary Cancer Cohort of Central China (CCGLC-002)

Hepatocellular Carcinoma | Biliary Tract Neoplasms

China
Tongji Hospital
The Second Affiliated Hospital of Fujian Medical University; Geneplus-Beijing... and other collaborators

Recruiting

Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma (CCGLC-008)

Hepatocellular Carcinoma Non-resectable

China
Wan-Guang Zhang
The Second Affiliated Hospital of Fujian Medical University; Geneplus-Beijing... and other collaborators

Recruiting

Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma (CCGLC-001)

Hepatocellular Carcinoma Non-resectable

China
Chen Li
Southwest University, China; Sichuan University ，China; The First Affiliated... and other collaborators

Recruiting

Development and Application of Intelligent Diagnosis and Treatment Norms for Children and Adolescents With Mental Disorders

Depressive Disorder | ADHD | ASD | AD

China
West China Hospital
Sun Yat-sen University; Peking University Cancer Hospital & Institute; Second... and other collaborators

Recruiting

Comparison of the Pathological Effect Between 2 and 4 Cycles Neoadjuvant CAPOX for Low/Intermediate Risk II/III Rectal Cancer (COPEC)

Rectal Cancer | Neoadjuvant Chemotherapy

China

Clinical Trials Sponsored by Shen Zhen Wingor Biotechnology CO. LTD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations